Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
- DOI
- 10.1002/cpt.2149
- Published
- 2021 Oct
- Container
- Clinical pharmacology and therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cpt.2149,
title = {Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.},
author = {Crews KR and Monte AA and Huddart R and Caudle KE and Kharasch ED and Gaedigk A and Dunnenberger HM and Leeder JS and Callaghan JT and Samer CF and Klein TE and Haidar CE and Van Driest SL and Ruano G and Sangkuhl K and Cavallari LH and Müller DJ and Prows CA and Nagy M and Somogyi AA and Skaar TC},
year = {2021},
journal = {Clinical pharmacology and therapeutics},
doi = {10.1002/cpt.2149},
url = {https://doi.org/10.1002/cpt.2149}
}RIS
TY - JOUR TI - Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. AU - Crews KR AU - Monte AA AU - Huddart R AU - Caudle KE AU - Kharasch ED AU - Gaedigk A AU - Dunnenberger HM AU - Leeder JS AU - Callaghan JT AU - Samer CF AU - Klein TE AU - Haidar CE AU - Van Driest SL AU - Ruano G AU - Sangkuhl K AU - Cavallari LH AU - Müller DJ AU - Prows CA AU - Nagy M AU - Somogyi AA AU - Skaar TC PY - 2021 JO - Clinical pharmacology and therapeutics DO - 10.1002/cpt.2149 UR - https://doi.org/10.1002/cpt.2149 ER -
APA
KR, C., AA, M., R, H., KE, C., ED, K., A, G., HM, D., JS, L., JT, C., CF, S., TE, K., CE, H., SL, V. D., G, R., K, S., LH, C., DJ, M., CA, P., M, N., AA, S., & TC, S. (2021). Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.2149
Source records
- pubmed · retrieved 2026-09-27T01:10:11.199Z